Xeltis
Clinical trials sponsored by Xeltis, explained in plain language.
-
New heart graft tested in first human study
Disease control ENROLLING_BY_INVITATIONThis study tests a new type of coronary artery bypass graft in 20 people with multi-vessel heart disease who need surgery. The goal is to see if the graft works safely and stays open for at least 30 days. Participants will be followed for up to 5 years to check for complications.
Phase: NA • Sponsor: Xeltis • Aim: Disease control
Last updated May 17, 2026 15:12 UTC
-
New graft offers hope for kidney patients who Can't get standard access
Disease control ENROLLING_BY_INVITATIONThis study is testing a new device called the aXess graft for people with end-stage kidney disease who need hemodialysis but cannot have a standard fistula. The graft is placed in the arm to create a reliable access point for dialysis. The study will check how safe the graft is a…
Phase: NA • Sponsor: Xeltis • Aim: Disease control
Last updated May 17, 2026 15:09 UTC